Healthcare innovations made in India, for India and the world Healthcare innovations made in India, for India and the world

Healthcare innovations made in India, for India and the world

overview

OVERVIEW

About the Program

India is an innovation powerhouse, and Pfizer is committed to nurture and support ideas that can prepare the healthcare systems to be future ready. The Pfizer INDovation Program will help accelerate the journey of six start-ups into the market through customized support and by fostering relevant cross-industry collaborations.

The Pfizer INDovation Program will help accelerate the journey of six start-ups into the market through customised support and by fostering relevant cross-industry collaborations.

Atal Innovation Mission, NITI Aayog, Agnii, Foundation for Innovation and Technology Transfer (FITT), IIT-Delhi, Pfizer and Social Alpha have come together to launch the Pfizer INDovation Program to support breakthrough healthcare innovations by start-ups in India. This program aims to equip healthcare systems for a post COVID-19 world. This initiative will guide high-quality startups, having at least a tested prototype, and accelerate their journey through product engineering and development services, clinical validation support, regulatory advisory, and market access opportunities through grant support and catalytic cross-industrial collaborations.

eligibility

Who Can Apply Who Can Apply Who Can Apply

ELIGIBILITY

Who Can Apply

Innovators and entrepreneurs building science and technology solutions, that have:

  1. A prototype in early or late-stage validation or above (TRL 4-5 or above)
  2. The potential to create and scale impact
  3. In markets across different geographies, and
  4. Has a sustainable business model

The program will focus on high problem statements in areas of digital health and oncology that have been selected after consultation with the program partners and advisors. The eligible enterprises working in any of the following areas are encouraged to apply:

details

DETAILS

Timelines & Offerings

Application Start Date
Application Start Date
5th April, 2022
Application Deadline
Application Deadline
15th May, 2022
Grand Jury
Grand Jury
Oncology - 11th July
Digital Health - 12th July
Results Declaration
Results Declaration
Date to be announced shortly
Incubation Begins
Incubation Begins
Date to be announced shortly
Grant Support

Grant Support

Grant of up to INR 65 Lakh for product validation, pilot testing and market access Grant

Venture Acceleration

Venture Acceleration

24-months engagement for curated technical and business advisory

Clinical Validation

Clinical Validation

Planning for clinical validation, trials and real-world evidence studies, access to test-beds

Regulatory Support

Regulatory Support

Guidance on product certification, regulatory approvals, patents and standards

Product Development Support

Product Development Support

Advisory support for Design for Manufacturing, Product development - Android, Cloud, UI/UX

Market Access and Scale-up Support

Market Access and Scale-up Support

Facilitation of introduction to national public/private healthcare systems through partner stakeholders

Fitt Incubation

Fitt Incubation

Access to FITT's support for product development, or any other approved technology incubation facility

Marketing and Branding

Marketing and Branding

Support for digital and print media coverage, showcasing opportunities

Business Advisory Workshops

Business Advisory Workshops

Workshops with experts, specialists, and sector leaders for developing the product market fit and go-to-market strategy

Access to Social Alpha Knowledge Services

Access to Social Alpha Knowledge Services

Access to renowned industry experts for mentoringand knowledge sessions conducted by Pfizer and Social Alpha

Opportunities for Follow-On Funding

Opportunities for Follow-On Funding

Opportunity to pitch for Social Alpha's seed support and pitch to a large and diverse investor and donor network

DETAILS

Program Design

The program will select 6 startups
The program will select 6 startups, preferably 3 each in Oncology and Digital Health, that will receive a grant of upto INR 65 Lakh to support and accelerate their lab to market journey.
The program is a 24 month cohort-driven engagement
The program is a 24 month cohort-driven engagement; however, the durations will vary based on the needs of each start-up and the implementation partner they would be working with.
The first month will be an orientation to the launchpad
The first month will be an orientation to the launchpad, where the portfolio managers will engage with the entire cohort, a preliminary introduction to the program would be given, and an understanding of the ecosystem challenges the startups face will be noted.
dedicated portfolio manager
Each startup will be allocated a dedicated portfolio manager to carry out an in-depth requirement mapping, and create a customized acceleration calendar for each winner.

contact

CONTACT

Got Queries?

For any assistance, please reach out to us at [email protected]. Or fill the form out and we'll get back to you.

Please find here our FAQ Please find here our FAQ

FAQ

Please find here our FAQ

Find the FAQ here

COLLABORATORS

Our Partners

A mission-aligned, cross-industry collaboration has come together to support the selected winners to build contextual solutions for strengthening India's healthcare system, and achieve wider market access in India, and the world.

Indian Institute of Technology Delhi
HCG
Social alpha
Agnii
FITT
IIT Kanpur
HIMSS
Health Innovation Exchange
Cytecare
Renalyx
Design Alpha
Grow Xponentially
FICCI
PATH
startupindia
NITI Aayog
He shall live
Google for Startups
Marico Innovation Foundation
AHPI